(Q79426717)
Statements
No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis (English)
Markus Ditschkowski
Ahmet H Elmaagacli
Rudolf Trenschel
Nina K Steckel
Michael Koldehoff
Dietrich W Beelen
1 December 2006